Literature DB >> 26847093

Infliximab or biosimilars in sarcoidosis; to switch or not to switch?

M Veltkamp1, M Drent, R P Baughman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26847093

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN： 1124-0490            Impact factor:   0.670


× No keyword cloud information.
  4 in total

Review 1.  Management of neurosarcoidosis: a clinical challenge.

Authors:  Mareye Voortman; Marjolein Drent; Robert P Baughman
Journal:  Curr Opin Neurol       Date:  2019-06       Impact factor: 5.710

Review 2.  Treatment of Sarcoidosis: A Multidisciplinary Approach.

Authors:  Alicia K Gerke
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

3.  A Rare Case of Renal Sarcoidosis.

Authors:  Zeeshan Zia; Qasim Z Iqbal; Raffaele A Ruggiero; Sami Pervaiz; Michel Chalhoub
Journal:  Cureus       Date:  2021-06-07

4.  Ranking Self-reported Gastrointestinal Side Effects of Pharmacotherapy in Sarcoidosis.

Authors:  M Drent; V L J Proesmans; M D P Elfferich; N T Jessurun; S M G de Jong; N M Ebner; E D O Lewis; A Bast
Journal:  Lung       Date:  2020-01-20       Impact factor: 2.584
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.